Business
Agreement with Weight Management Company
OptiBiotix Health plc (AIM: OPTI) announced a distribution agreement with a major direct-selling weight management company. OptiBiotix will supply SlimBiome® and WellBiome® products for the distributor's own-brand products. The distributor plans a phased launch, beginning in its largest sales territory, followed by other European countries, using existing consultant and e-commerce channels. A first order is anticipated within three months, with a product launch expected in the first half of 2026. This agreement reflects growing consumer interest in natural alternatives to anti-obesity drugs, driven by the demand for products that reduce hunger and cravings. Disclaimer*
About this update from Optibiotix Health Plc
[{"type":"text","content":"\n\nOptiBiotix Health plc\n(\"OptiBiotix\" or the \"Company\" or \"the Group\")\n \nAgreement with well-known Weight Management Company\n \nOptiBiotix Health plc (AIM: OPTI), a life sciences business developing products which reduce hunger and food cravings, enhance the gut microbiome, and sweet fibres as healthy sugar substitutes announces the signing of a distribution agreement with a well-known direct selling weight management company (the \"Distributor\").\n \nOptiBiotix will provide a range of SlimBiome® finished products under the Distributor's own branding and a WellBiome® product which will be included in their product range. The Distributor plans to launch in its biggest territory by sales first, which, if successful, will be followed by subsequent launches in other European countries. The products will be sold via a long standing and established distribution channel of consultants and via e-commerce. As part of this agreement, a first order is expected to be placed within the first three months of signing the agreement. Further information on the Distributor and brand will be announced on launch which OptiBiotix anticipates will be in H1 2026.\n \nThis agreement reflects the interest OptiBiotix is seeing in bringing functionality to weight management with traditional brands looking to leverage the interest in products which reduce hunger and cravings generated by the anti-obesity drugs. This agreement opens new opportunities to include science backed functional ingredients into well-known weight management brands.\n \nStephen O'Hara, CEO of OptiBiotix Health plc said: \"We are pleased to announce this agreement with a well-known and established weight management company. This agreement brings together the trust, loyalty, and customer base of a recognised brand with the science and functionality of SlimBiome®.\n \n\"Following the launch of anti-obesity drugs, natural, scientifically proven, non-drug alternatives to reduce hunger and cravings are actively being sought by consumers. This announcement demonstrates that the science and multiple human studies carried out on SlimBiome® is attracting the interest of major brands around the world.\"\n \nThe Directors of the Company are responsible for the release of this announcement.\n \nFor further information, please contact:\n&n...